You are here
- Home
- Therapy Areas
- Cardiovascular
The EXTEND Study: A Randomized, Double-Blind, Parallel-Group, Phase III b, Multi-Centre Study Evaluating Extended Prophylactic Treatment With Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events in Patients Undergoing Elective Hip Replacement or Hip Fracture Surgery.
- Disease
- venous thromboembolism
- Drug Name
- Exanta
- Generic Name
- ximelagatran
- Sponsor
- AstraZeneca
- Drug Status
- Discontinued
- Phase
- IIIb
- Start Date
- Sep 7, 2005
- Study Name
- D4003C00030
- Study Id
- D4003C00030
- ClinicalTrials.gov ID
- NCT00206089
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
